Viking Therapeutics Inc. (VKTX)

Viking Therapeutics Inc. (VKTX $37.58)
- $37.58 Cap: $3.94B
- View VKTX Profile
- View Questions on VKTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Crocs Inc. (CROX $80.65)
- $80.65 P/E (TTM): 22.71X Cap: $4.50B
- View CROX Profile
- View Questions on CROX
Aspen Aerogels Inc. (ASPN $7.95)
- $7.95 Cap: $620M
- View ASPN Profile
- View Questions on ASPN
Viking Therapeutics Inc. (VKTX $37.58)
- $37.58 Cap: $3.94B
- View VKTX Profile
- View Questions on VKTX
Nu Holdings Ltd. Class A (NU $15.97)
- $15.97 Cap: $77.38B
- View NU Profile
- View Questions on NU
TransMedics Group Inc. (TMDX $129.05)
- $129.05 P/E (TTM): 69.17X Cap: $4.63B
- View TMDX Profile
- View Questions on TMDX

Q: I currently own the following at a loss: ASPN, CROX, NU, TMDX, VKTX

You suggestions on which to:

1. Sell and look elsewhere for better opportunity
2. Sell and rebuy in 30 days
3. Add into current weakness

Read Answer Asked by Kel on December 02, 2024

Amgen Inc. (AMGN $294.16)
- $294.16 P/E (TTM): 23.84X Cap: $157.20B
- View AMGN Profile
- View Questions on AMGN
Abbott Laboratories (ABT $123.50)
- $123.50 P/E (TTM): 15.61X Cap: $216.78B
- View ABT Profile
- View Questions on ABT
Pfizer Inc. (PFE $24.57)
- $24.57 P/E (TTM): 12.92X Cap: $138.10B
- View PFE Profile
- View Questions on PFE
AstraZeneca PLC (AZN $81.58)
- $81.58 P/E (TTM): 37.27X Cap: $256.98B
- View AZN Profile
- View Questions on AZN
Viking Therapeutics Inc. (VKTX $37.58)
- $37.58 Cap: $3.94B
- View VKTX Profile
- View Questions on VKTX

Q: Aside from LLY and NVO, what other healthcare companies might enjoy success with weight loss drugs or products related to them? I’ve heard good things about ABT., AMGN, PFE, AZN, RHHBY and others in this regard, but I was wondering how you might rank them and/or others (most promising names first). I’m quite interested in Roche which has been showing strength after a long period of weakness (it’s now $35.69 as of Friday July 12).

Read Answer Asked by Brian on July 16, 2024

Viking Therapeutics Inc. (VKTX $37.58)
- $37.58 Cap: $3.94B
- View VKTX Profile
- View Questions on VKTX

Q: Your thoughts on this company. At what price would you consider it a speculative buy. Thanks

Read Answer Asked by Charles on April 01, 2024